Skip to main content
CLDX logo
CLDX
(NASDAQ)
Celldex Therapeutics, Inc.
$32.43-- (--)
Loading... - Market loading

Celldex Therapeutics (CLDX) Stock Price & Financial Analysis

Celldex Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$32.35 - $34.14
52-Week High$35.79
52-Week Low$19.52
Open$33.69
Volume2.38M
Average Volume (3M)842.61K
Market Cap2.16B
Shares Outstanding66.57M
Price to Sales (P/S)2632.60
Price to Book (P/B)4.73
EV/EBITDA-7.22
Revenue (TTM)820.00K
Net Income (TTM)-283.69M
Free Cash Flow (TTM)-225.96M
EPS (TTM)$-4.27
Profit Margin-34596.22%
Operating Margin-37694.63%
Return on Equity (ROE)-62.18%
Debt to Equity0.00
50-Day MA$32.02
200-Day MA$28.00
52-Week Change55.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Celldex Therapeutics

What is the current stock price for CLDX?

As of the latest trading session, CLDX stock trades at $32.43. The 52-week range is $19.52–$35.79, with a day range of $32.35–$34.14.

What is the P/E ratio for CLDX?

The P/E ratio (Price-to-Earnings) for CLDX is shown in the Key Statistics section. This valuation metric helps compare Celldex Therapeutics, Inc. to industry peers.

Does CLDX pay dividends?

Celldex Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CLDX?

Based on 11 analysts, the consensus for CLDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CLDX?

Celldex Therapeutics's market capitalization is $2.16B, classifying it as a mid-cap company. Celldex Therapeutics operates in the Healthcare sector within the Biotechnology industry.